
|Articles|May 1, 2001
Combo of biological vaccine, chemo looks promising in early tests
New York - Combining biological vaccines with chemotherapy after surgery may increase life expectancies for patients in the most critical stages of melanoma, according to Steven O' Day, M.D., John Wayne Cancer Institute, Santa Monica, Calif.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Utilizing CYP2C9 Testing and JAK Inhibitors for Alopecia Areata
4
Timing, Severity, and Therapeutic Choice in Moderate to Severe HS
5


















